Marty Richardson

2.9k total citations · 1 hit paper
47 papers, 2.0k citations indexed

About

Marty Richardson is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marty Richardson has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marty Richardson's work include Tuberculosis Research and Epidemiology (6 papers), Mosquito-borne diseases and control (6 papers) and Malaria Research and Control (6 papers). Marty Richardson is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Mosquito-borne diseases and control (6 papers) and Malaria Research and Control (6 papers). Marty Richardson collaborates with scholars based in United Kingdom, South Africa and Switzerland. Marty Richardson's co-authors include Paul Garner, Sarah Donegan, Christian Lengeler, Joseph Pryce, Kerry Dwan, Rima E. Rudd, Gill Rowlands, Joanne Protheroe, Paul T. Seed and Dheeraj Shah and has published in prestigious journals such as PLoS ONE, Cochrane Database of Systematic Reviews and Behaviour Research and Therapy.

In The Last Decade

Marty Richardson

45 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interpretation of subgroup analyses in systematic reviews: A tutorial

2018 398 citations Marty Richardson, Paul Garner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marty Richardson United Kingdom	23	422	418	366	343	272	47	2.0k
Tamoghna Biswas India	12	230 0.5×	477 1.1×	381 1.0×	272 0.8×	274 1.0×	52	2.5k
Hmwe Hmwe Kyu United States	18	217 0.5×	474 1.1×	265 0.7×	236 0.7×	216 0.8×	34	1.7k
Shayesteh Jahanfar United States	25	229 0.5×	678 1.6×	334 0.9×	285 0.8×	613 2.3×	191	2.4k
Phoebe Williams Australia	23	490 1.2×	326 0.8×	641 1.8×	234 0.7×	159 0.6×	98	1.9k
Meenu Singh India	29	520 1.2×	261 0.6×	641 1.8×	200 0.6×	226 0.8×	181	2.9k
Tara M. Vogt United States	21	462 1.1×	234 0.6×	717 2.0×	268 0.8×	114 0.4×	48	2.1k
Poul‐Erik Kofoed Denmark	28	360 0.9×	1.0k 2.4×	311 0.8×	770 2.2×	341 1.3×	148	3.1k
Rosa Maria Salani Mota Brazil	28	887 2.1×	276 0.7×	639 1.7×	264 0.8×	126 0.5×	127	2.3k
Álvaro A. Cruz Brazil	39	340 0.8×	551 1.3×	460 1.3×	335 1.0×	224 0.8×	214	6.6k
Victor Santana Santos Brazil	25	767 1.8×	218 0.5×	263 0.7×	227 0.7×	186 0.7×	122	1.7k

Countries citing papers authored by Marty Richardson

Since Specialization

Citations

This map shows the geographic impact of Marty Richardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marty Richardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marty Richardson more than expected).

Fields of papers citing papers by Marty Richardson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marty Richardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marty Richardson. The network helps show where Marty Richardson may publish in the future.

Co-authorship network of co-authors of Marty Richardson

This figure shows the co-authorship network connecting the top 25 collaborators of Marty Richardson. A scholar is included among the top collaborators of Marty Richardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marty Richardson. Marty Richardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fleeman, Nigel, Rachel Houten, A Bagust, et al.. (2020). Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. Health Technology Assessment. 24(2). 1–180. 30 indexed citations

Duarte, Rui, Angela Stainthorpe, J Greenhalgh, et al.. (2019). The clinical and cost effectiveness of lead-I electrocardiogram (ECG) devices for detecting atrial fibrillation using single-time point testing in primary care: a systematic review and economic evaluation. Health Technology Assessment. 1 indexed citations

Richardson, Marty, Jamie J Kirkham, Kerry Dwan, et al.. (2019). Protocol for the development of the STrengthening the Reporting Of Pharmacogenetic Studies (STROPS) guideline: checklist of items for reporting pharmacogenetic studies. BMJ Open. 9(7). e030212–e030212. 3 indexed citations

Duarte, Rui, Angela Stainthorpe, James Mahon, et al.. (2019). Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation. PLoS ONE. 14(12). e0226671–e0226671. 17 indexed citations

Fleeman, Nigel, A Bagust, Rui Duarte, et al.. (2019). Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - Open. 3(3). 293–302. 1 indexed citations

Budhathoki, Shyam Sundar, et al.. (2019). Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis. Cochrane Database of Systematic Reviews. 2019(1). CD003753–CD003753. 27 indexed citations

Stainthorpe, Angela, J Greenhalgh, A Bagust, et al.. (2018). Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 36(10). 1153–1163. 11 indexed citations

Pryce, Joseph, Leslie Choi, Marty Richardson, & David Malone. (2018). Insecticide space spraying for preventing malaria transmission. Cochrane Database of Systematic Reviews. 12 indexed citations

Maia, Marta F., Merav Kliner, Marty Richardson, Christian Lengeler, & Sarah Moore. (2018). Mosquito repellents for malaria prevention. Cochrane Database of Systematic Reviews. 2018(2). CD011595–CD011595. 58 indexed citations

10.

Paul, Mical, et al.. (2018). Vaccines for preventing typhoid fever. Cochrane Database of Systematic Reviews. 2018(5). 101 indexed citations

11.

Gleave, Katherine, Natalie Lissenden, Marty Richardson, & Hilary Ranson. (2017). Piperonyl butoxide (PBO) combined with pyrethroids in long-lasting insecticidal nets (LLINs) to prevent malaria in Africa. Cochrane Database of Systematic Reviews. 13 indexed citations

12.

Fleeman, Nigel, A Bagust, Sophie Beale, et al.. (2017). Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 36(3). 289–299. 3 indexed citations

13.

Richardson, Marty, Jamie J Kirkham, Kerry Dwan, et al.. (2017). Influence of genetic variants on toxicity to anti-tubercular agents: a systematic review and meta-analysis (protocol). Systematic Reviews. 6(1). 142–142. 13 indexed citations

14.

Fleeman, Nigel, A Bagust, Angela Boland, et al.. (2017). Talimogene Laherparepvec for Treating Metastatic Melanoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 35(10). 1035–1046. 6 indexed citations

15.

Kelly, Christine, Katherine M. Gaskell, Marty Richardson, et al.. (2016). Discordant Immune Response with Antiretroviral Therapy in HIV-1: A Systematic Review of Clinical Outcomes. PLoS ONE. 11(6). e0156099–e0156099. 46 indexed citations

16.

Yotsu, Rie, Marty Richardson, & Norihisa Ishii. (2016). Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease). Cochrane Database of Systematic Reviews. 8. CD012118–CD012118. 18 indexed citations

17.

Gera, Tarun, Dheeraj Shah, Paul Garner, Marty Richardson, & Harshpal Singh Sachdev. (2016). Integrated management of childhood illness (IMCI) strategy for children under five. Cochrane Database of Systematic Reviews. 2016(6). CD010123–CD010123. 130 indexed citations

18.

Mbuagbaw, Lawrence, et al.. (2015). Health system and community level interventions for improving antenatal care coverage and health outcomes. Cochrane Database of Systematic Reviews. 2016(3). CD010994–CD010994. 119 indexed citations

19.

Rowlands, Gill, et al.. (2015). A mismatch between population health literacy and the complexity of health information: an observational study. British Journal of General Practice. 65(635). e379–e386. 167 indexed citations

20.

Fleeman, Nigel, A Bagust, Sophie Beale, et al.. (2015). Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective. PharmacoEconomics. 33(9). 893–904. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact